Objective To investigate the distribution of gender,age,and traditional Chinese medicine(TCM)syndrome elements and syndrome types in patients suffering from novel coronavirus infection complicated with asthma,and to explore the medication rules for the patients,thus to provide reference for the formulation of clinical diagnosis and treatment plans for novel coronavirus infection complicated with asthma.Methods From December 2022 to January 2023,the information of gender,age,syndrome elements,TCM syndrome types and medication frequency of the herbal medicine was collected among the patients suffering from novel coronavirus infection complicated with asthma who were treated in outpatient clinics of the respiratory department and emergency department of Shenzhen Traditional Chinese Medicine Hospital.The information data were statistically analyzed and then the network visualization of results was presented.Results A total of 63 cases were included,including 27 males and 36 females,with an average age of 51.8 years old.Thirteen TCM syndrome types were involved,of which the three with the leading occurrence frequency were wind-phlegm syndrome(17 cases),spleen deficiency with dampness accumulation syndrome(11 cases),and phlegm-heat stagnation in the lung syndrome(8 cases).There were four disease-location syndrome elements,and the top two were lung(36 cases)and spleen(12 cases).Eight disease-nature syndrome elements were involved,and the top three were wind(36 cases),phlegm(28 cases)and qi deficiency(24 cases).A total of 128 Chinese herbal medicines were used,and their properties and flavors were predomiated by being pungent,bitter,sweet and cold.Most of the Chinese herbal medicines had the meridian tropism of lung,spleen,liver and stomach meridians,and most of the Chinese herbal medicines had the therapeutic actions of resolving phlegm,easing cough and relieving asthma.The top four Chinese herbal medicines with higher medication frequency were Glycyrrhizae Radix et Rhizoma(51 times),Ephedrae Herba(47 times),blanching Armeniacae Semen Amarum(44 times),and Schisandrae Chinensis Fructus(40 times).The core two-drug groups were Ephedrae Herba-Glycyrrhizae Radix et Rhizoma,Ephedrae Herba-Schisandrae Chinensis Fructus,and blanching Armeniacae Semen Amarum-Pinelliae Rhizoma.The core three-drug groups were Pinelliae Rhizoma-blanching Armeniacae Semen Amarum-Ephedrae Herba,and Ephedrae Herba-Schisandrae Chinensis Fructus-Glycyrrhizae Radix et Rhizoma.Conclusion Pathogenic phlegm retention in lung is the core pathogenesis of novel coronavirus infection complicated with asthma,which is protracted through the disease.The pathogenic wind is the driving factor of the disease's development and progression,and in the middle and late stages of the disease,the complicated syndrome manifestations of pathogenic heat,qi deficiency,qi and yin deficiency,and blockage of upper orifice are commonly seen.Its therapeutic principles are to relieve exterior syndrome and clear heat,resolve phlegm,ease cough and relieve asthma,thus to restore the qi movement of the zang-fu organs,support the healthy qi,eliminate pathogens and strengthen body resistance.

Objective To investigate the distribution of traditional Chinese medicine(TCM)syndrome patterns and medication characteristics in corona virus disease 2019(COVID-19)patients complicated with chronic bronchitis at the initial phase of the termination of pandemic control policy in Shenzhen,and to provide evidence for TCM syndrome differentiation and treatment of these patients.Methods A retrospective analysis was performed on 76 COVID-19 patients complicated with chronic bronchitis who visited the Department of Respiratory and Critical Care Medicine or the Emergency Internal Medicine Clinic at Shenzhen Traditional Chinese Medicine Hospital between December 15,2022 and February 28,2023,an initial phase of the termination of pandemic control policy in Shenzhen.Data of demographics,TCM syndrome patterns,and herbal prescriptions were collected.TCM syndrome distribution and medication patterns of the COVID-19 patients complicated with chronic bronchitis were summarized to enhance understanding of post-COVID sequelae,post-COVID syndrome,long COVID,post-infectious cough,and chronic cough,and to provide references for TCM management of acute/chronic post-COVID cough,long COVID syndrome,and emerging respiratory infectious diseases.Results A total of 76 medical records with full information were included,covering 63 herbal formulas and 140 herbal medicinals were analyzed.The most common TCM syndrome pattern was phlegm-turbidity obstructing the lung syndrome,followed by phlegm-heat stagnating the lung syndrome and lung qi deficiency syndrome.The properties of the herbs used were predominantly warm,cold,or mild;their flavors were bitter,pungent,or sweet;and their meridian tropisms primarily involved the lung,spleen,stomach,and liver.Twenty-five medicinals used exceeding 15 times in the formulas were identified,including Glycyrrhizae Radix et Rhizoma(Gancao),Ephedrae Herba(Mahuang),Coicis Semen(Yiyiren),and Poira(Fuling).Association rule analysis revealed the frequent herbal pairs of Gancao-Mahuang,Belamcandae Rhizoma(Shegan)-Mahuang,Gancao-Fuling,Fuling-Yiyiren,etc.Cluster analysis categorized high-frequency herbs into four distinct groups.Conclusion The retrospective analysis highlights the complexity of clinical manifestations in COVID-19 patients complicated with chronic bronchitis at the initial phase of the termination of pandemic control policy in Shenzhen.The pathogenic factors of the patients predominantly involve phlegm-turbidity and phlegm-heat.Therapeutic principles for the patients focus on diffusing the lung to alleviate adverse flow of qi,resolving phlegm and removing dampness,and clearing and draining damp-heat.Commonly prescribed formulas include San'ao Decoction,Yuebi Plus Banxia Decoction,Xiaoqinglong Decoction,Shegan Mahuang Decoction,and Suhuang Zhike Decoction,and the formulas are used by modification according to the symptoms.